Dilate

Dilate1%

Ophthalmic Solution

Tropicamide

Incepta Pharmaceuticals Ltd.

Product Code : 4998
MRP 76.00
10% Off
Best PriceTk
/
1
Section

Medicine overview

Indications of Dilate 1%

For mydriasis and cycloplegia for diagnostic procedure, for the treatment of acute and subacute iridocyclitis, chronic iridocyclitis, Adhesions and disruptions of iris and ciliary body, Sclera and iris operations

Theropeutic Class

Mydriatic and Cycloplegic agents

Pharmacology

Dilate 1% binds to and blocks the receptors in the muscles of the eye (muscarinic receptor M4). Dilate 1% acts by blocking the responses of the iris sphincter muscle to the iris and ciliary muscles to cholinergic stimulation, producing dilation of the pupil and paralysis of the ciliary muscle.

Dosage & Administration of Dilate 1%

For refraction: Instill one or two drops of 1% solution in the eye(s), repeated in five minutes. If patient is not seen within 20 to 30 minutes, an additional drop may be instilled to prolong mydriatic effect.For examination of fundus: instill one or two drops of 0.5% solution 15 to 20 minutes prior to examination. Individuals with heavily pigmented irides may require higher strength or more doses.

Dosage of Dilate 1%

For refraction: Instill one or two drops of 1% solution in the eye(s), repeated in five minutes. If patient is not seen within 20 to 30 minutes, an additional drop may be instilled to prolong mydriatic effect.For examination of fundus: Instill one or two drops of 0.5% solution 15 to 20 minutes prior to examination. Individuals with heavily pigmented irides may require higher strength or more doses.

Interaction of Dilate 1%

Dilate 1% may interfere with the antihypertensive action of carbachol, pilocarpine, or ophthalmic cholinesterase inhibitors.

Contraindications

Contraindicated in persons showing hypersensitivity to any component of this preparation.

Side Effects of Dilate 1%

Transient stinging, blurred vision, photophobia and superficial punctate keratitis have been reported with the use of Dilate 1%. Increased intraocular pressure has been reported following the use of mydriatics. Dryness of the mouth, tachycardia, headache, allergic reactions, nausea, vomiting, pallor, central nervous system disturbances and muscle rigidity have been reported with the use of Dilate 1%.

Pregnancy & Lactation

Pregnancy Category C. Dilate 1% should be given to a pregnant woman only if clearly needed. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Dilate 1% is administered to a nursing woman.

Precautions & Warnings

The lacrimal sac should be compressed by digital pressure for 2-3 minutes after instillation to avoid excessive systemic absorption.

Storage Conditions

Store at 15° to 25°C . Do not refrigerate or store at high temperatures. Keep container tightly closed.

Drug Classes

Mydriatic and Cycloplegic agents

Mode Of Action

Dilate 1% binds to and blocks the receptors in the muscles of the eye (muscarinic receptor M4). Dilate 1% acts by blocking the responses of the iris sphincter muscle to the iris and ciliary muscles to cholinergic stimulation, producing dilation of the pupil and paralysis of the ciliary muscle.

Pregnancy

Pregnancy Category C. Dilate 1% should be given to a pregnant woman only if clearly needed. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Dilate 1% is administered to a nursing woman.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.